Erector Spinae Block Versus PENG Block for Hip Replacement
- Conditions
- Pain, Postoperative
- Registration Number
- NCT05796804
- Lead Sponsor
- Papa Giovanni XXIII Hospital
- Brief Summary
THR (Total Hip Replacement) can be very painful and regional anesthesia is very effective in reducing postoperative pain. Erector Spinae Plane Block (ESPB) and PENG (pericapsular nerve group block) are alternative approaches to the hip sensitive nerve branches that resulted to be very promising for hip surgeries. However, no studies investigated the analgesic superiority of either PENG or ESPB. In our study the investigators compare PENG (with a lateral femoral cutaneous nerve block) and ESPB in terms of pain relief expressed as morphine consumption in the first 24 hours after primary THR.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 64
- primary total hip replacement
- informed consent
- allergies to study drugs
- spinal anesthesia contraindicated
- kidney failure
- epilepsy, psychiatric disease, neurologic deficits
- revision surgery
- neuropathies in the lumbar area
- no informed consent
- pregnancy
- alcohol/opioid abuse
- emergency surgery/intensive care
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method morphine consumption 24 hours milligrams of morphine by patient controlled analgesia intravenously
- Secondary Outcome Measures
Name Time Method postoperative pain 48 hours numeric rating scale - NRS 11 point scale from 0 = "no pain" to 10 = "worst imaginable pain"
chronic postoperative pain 3 months numeric rating scale 11 point scale from 0 = "no pain" to 10 = "worst imaginable pain"
neuropathic pain 48 hours DN4 questionnaire - 4 items questionnaire to investigate the occurrence of neuropathic component
postoperative complications 48 hours nausea, vomiting, vertigo, blurred vision, syncope, bleeding, falls
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Aast Papa Giovanni Xxiii
🇮🇹Bergamo, Italy
Aast Papa Giovanni Xxiii🇮🇹Bergamo, Italy